VAXX - Vaxxinity GAAP EPS of -$0.14 beats by $0.24 August, 11 2022 09:17 AM Vaxxinity Inc. Vaxxinity press release ( NASDAQ: VAXX ): Q2 GAAP EPS of -$0.14 beats by $0.24 . As of June 30, 2022, cash and cash equivalents were $109.1 million, as compared to $144.9 million on December 31, 2021. Shares +1.28% PM. For further details see: Vaxxinity GAAP EPS of -$0.14 beats by $0.24